ArticleFrontiers in immunology2022

Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.

Marijne Vandebergh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.